News

Gladstone in the News July 19, 2024

With COVID Summer Wave Underway, When Should You Get Your Next Vaccine Shot?

San Francisco Chronicle—With the United States now experiencing a typical summer COVID surge, Gladstone Senior Investigator Nadia Roan helps break down how to make a personal decision about when to get your next vaccine.

Gladstone Experts COVID-19 Virology Roan Lab

Gladstone in the News March 4, 2024

The Blood Holds Clues to Understanding Long COVID

Science News—In some people with long COVID, powerful immune players called T cells seem to go out of whack. In some long COVID patients, T cells that recognize SARS-CoV-2 can become exhausted, Nadia Roan's team reported in Nature Immunology in January. And scientists know that tired-out T cells can have trouble wiping out infection.

Research (Publication) COVID-19 Virology Roan Lab

Gladstone in the News January 18, 2024

Could Long COVID’s Signs of Immune Dysregulation in the Blood Lead to a Diagnostic Test?

STAT—New research has identified proteins present in the blood of people with long COVID that could point the way to a much-needed diagnostic test and possibly to future therapeutic targets. “The dysregulation they observed is a bit complex, as some complement components go up and others go down, but overall the results suggest that complement pathways are abnormal in people with long COVID,” said Gladstone's Nadia Roan, the senior author of a Nature Immunology paper published earlier in January on immune response in long COVID.

Gladstone Experts COVID-19 Roan Lab

Gladstone in the News January 12, 2024

‘Striking’ Study Reveals Immune System Anomalies in People with Long COVID

San Francisco Chronicle—At least 10 percent of those who survive COVID continue to face debilitating symptoms months after the acute infection resolves. New research from the laboratory of Gladstone Senior Investigator Nadia Roan shows that individuals suffering Long Covid have a dysregulated immune response to the virus and evidence of T cell exhaustion, which may be due to the virus persisting within their bodies.

Gladstone Experts COVID-19 Virology Roan Lab

Article January 11, 2024

In Patients with Long COVID, Immune Cells Don’t Follow the Rules

Scientists at Gladstone Institutes and UC San Francisco analyzed immune cells in people with and without long COVID, making significant discoveries that will help answer questions about what causes the condition and how to treat it

News Release Research (Publication) COVID-19 Virology Roan Lab

Gladstone in the News May 3, 2023

Should I Bother Getting a Bivalent COVID Booster Now?

San Francisco Chronicle—Gladstone Senior Investigator Nadia Roan explains that while prior vaccination or exposure to COVID-19 may confer long-term protection against serious disease, a booster shot with the bivalent vaccine will protect you for a few months against new infection.

Gladstone Experts COVID-19 Virology Roan Lab

Article December 20, 2022

Biomedical Research That “Flows” in New Directions

Improvements in the cell analysis technique known as flow cytometry are helping Gladstone researchers make discoveries in immunology, stem cell biology, cardiology, and neuroscience

Gladstone Experts Flow Cytometry Core Neurological Disease Alexanian Lab Roan Lab

Article December 16, 2022

Tips from Virologists to Face the “Tripledemic” This Holiday Season

Gladstone scientists answer questions about the convergence of COVID-19, RSV, and the flu this winter

Gladstone Experts COVID-19 Virology Greene Lab Ott Lab Roan Lab

Gladstone in the News December 10, 2022

New COVID Subvariants Are ‘the Most Immune Evasive Yet.’ Here’s What That Means

San Francisco Chronicle—New SARS-CoV-2 subvariants are driving an increase in COVID case numbers around the world. Gladstone Investigator Nadia Roan explains that the subvariants have mutations that help them evade neutralizing antibodies, but stresses that getting the bivalent vaccine can still help strengthen immunity to the ever-changing virus.

Gladstone Experts COVID-19 Virology Roan Lab

Gladstone in the News October 20, 2022

Scientists Explain What We Should Expect as COVID Variants Xbb, Bq.1 Spread in Europe, Asia

ABC7 News—Senior Investigator Nadia Roan, PhD, says that a winter surge of infections from the highly transmissible new variants of SARS-CoV-2 currently emerging in the US is likely, but it remains unclear how bad it will be.

Gladstone Experts COVID-19 Virology Roan Lab

Gladstone in the News October 16, 2022

How Long Does Immunity from the New COVID Bivalent Boosters Last ’in the Real World’?

San Francisco Chronicle—The new bivalent COVID-19 booster shots are recommended for individuals age 5 and up who are at least two months past their last vaccine dose. Gladstone Investigator Nadia Roan explains that the bivalent boosters greatly increase the levels of antibodies that can prevent the Omicron variant from infecting cells.

Gladstone Experts COVID-19 Virology Roan Lab

Gladstone in the News September 10, 2022

When’s the Best Time to Get the New COVID Booster Shot? Here’s What Experts Say

San Francisco Chronicle—New COVID-19 booster shots targeting both the ancestral virus and omicron strains are now available. Gladstone Investigator Nadia Roan weighs in on when people should get the jab, based on the timing of their last dose and whether they’ve been recently infected.

Gladstone Experts COVID-19 Virology Roan Lab

Gladstone in the News July 19, 2022

Finding HIV’s “Sweet Spot”

NIH Director’s Blog—Recent work from the team of Gladstone Associate Investigator Nadia Roan, PhD, and their colleagues at The Wistar Institute is featured in this week's NIH Director's Blog. The work uncovers intriguing evidence for the role of sugars at the surface of immune cells in HIV infection.

Gladstone Experts HIV/AIDS Virology Roan Lab

Article July 5, 2022

Finding HIV’s Sweet Spot

Gladstone scientists uncover novel aspects of HIV infection by monitoring sugars at the surface of individual immune cells

News Release Research (Publication) HIV/AIDS Virology Roan Lab

Gladstone in the News June 30, 2022

Omicron Subvariants BA.4, BA.5 Are Spreading ‟Like Wildfire”, Becoming Dominant Strains in US

ABC7 News—As Omicron BA.4 and BA.5 variants overtake previous coronavirus variants across the United States, Gladstone Associate Investigator Nadia Roan, PhD, explains that their success may owe both to their ability to escape our immune system and to their accelerated replication rate. She suggests that more effort should be made to block infection at the level of the airways, the virus's entry point into our body.

Gladstone Experts COVID-19 Roan Lab